StockData

American Superconductor vs Aspen Aerogels

AMSC and ASPN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AMSC and ASPN compare

American Superconductor is the larger company, worth 2.5 times as much as Aspen Aerogels ($1.2B against $463M).

American Superconductor grew revenue faster over the last twelve months (31.1% versus −39.3% for Aspen Aerogels).

American Superconductor keeps more of each dollar of sales as profit, with a net margin of 38.6% compared with −60.8% at Aspen Aerogels.

American Superconductor scores higher on the StockData Score (12 against 4 for Aspen Aerogels), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAMSCASPN
Size and price
Market cap$1.2B$463M
Share price$24.13$5.58
Change, 1 year−31.4%62.7%
Change, 5 years68.7%−91.0%
Beta (5Y)2.152.17
Employees1,195854
StockData Score
Total score12 (better)4
Valuation score2 (better)0
Growth score2 (better)1
Performance score3 (better)0
Health score5 (better)3
Dividend score00
Valuation
P/E8.1×–
P/S3.3×2.2× (better)
P/B2.0× (better)2.5×
EV/EBITDA34.8×–
P/FCF–23.2×
FCF yield–4.3%
Fair value–$4.64
Margin of safety–−20.2%
Growth
Revenue growth (TTM)31.1% (better)−39.3%
Revenue growth, 5Y average28.0% (better)22.0%
Net income growth (TTM)790%–
EPS growth (TTM)705%–
Profitability
Gross margin28.0% (better)2.4%
Operating margin5.2% (better)−59.3%
Net margin38.6% (better)−60.8%
FCF margin–9.3%
Return on equity29.2% (better)−53.2%
Return on invested capital6.7% (better)−83.0%
Financial health
Debt / equity0.000.12 (better)
Current ratio2.38 (better)2.10
Altman Z-score2.84 (better)−2.72
Piotroski F-score7 (better)4
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions73.1%88.5%
Held by insiders3.5%16.8%
Insider net buying, 12 months−$7.8M (better)−$58.1M
Short interest, % of float9.1%9.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.